BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12401661)

  • 21. Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.
    Becker K; Mueller JD; Schulmacher C; Ott K; Fink U; Busch R; Böttcher K; Siewert JR; Höfler H
    Cancer; 2003 Oct; 98(7):1521-30. PubMed ID: 14508841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
    Wu Z; Ma S; Jing S; Deng Q; Zheng Z; Wu K; Li J; Chen S; Tang R; Li X
    Hepatogastroenterology; 2014 Jun; 61(132):972-7. PubMed ID: 26158151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer.
    Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS
    Oncology; 2001; 60(1):24-30. PubMed ID: 11150904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Perioperative chemotherapy vs. surgery alone in resectable gastroesophageal carcinomas. Results of the MAGIC study].
    Lordick F; Siewert JR
    Chirurg; 2006 Dec; 77(12):1166-7. PubMed ID: 17091285
    [No Abstract]   [Full Text] [Related]  

  • 26. Neoadjuvant and adjuvant chemotherapy of locally advanced stomach cancer.
    Morant R
    Onkologie; 2001 Apr; 24(2):116-21. PubMed ID: 11441289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Present state and prospects of adjuvant chemotherapy for gastric cancer].
    Hori T; Ozawa R; Hanayama H; Yamashita H; Kaibe N; Matsumoto T; Oshima T; Takemura M; Kikuchi S; Sasako M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1390-5. PubMed ID: 21918333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
    Tamura S; Fujitani K; Kimura Y; Tsuji T; Matsuyama J; Iijima S; Imamura H; Inoue K; Kobayashi K; Kurokawa Y; Furukawa H;
    Oncology; 2011; 80(5-6):296-300. PubMed ID: 21778769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer.
    Kim TW; Kang YK; Ahn JH; Chang HM; Yook JH; Oh ST; Kim BS; Lee JS
    Ann Oncol; 2002 Dec; 13(12):1893-8. PubMed ID: 12453857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy: survival benefit in gastric cancer.
    Das M
    Lancet Oncol; 2017 Jun; 18(6):e307. PubMed ID: 28483410
    [No Abstract]   [Full Text] [Related]  

  • 32. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intraperitoneal and intravenous chemotherapy and left upper abdominal evisceration for advanced gastric cancer.
    Nomura E; Niki M; Fujii K; Shinohara H; Nishiguchi K; Sonoda T; Tanigawa N
    Gastric Cancer; 2001; 4(2):75-82. PubMed ID: 11706764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multivisceral resection of advanced gastric cancer].
    Palaia R; Delrio P; Puppio B; Parisi V; Daniele B
    Tumori; 2003; 89(4 Suppl):121-4. PubMed ID: 12903568
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preoperative chemotherapy of gastric cancer].
    Skoronad VIu; Berdov BA
    Vopr Onkol; 2010; 56(2):226-33. PubMed ID: 20552903
    [No Abstract]   [Full Text] [Related]  

  • 37. Curative Gastrectomy with Perioperative Chemotherapy Improves the Survival for Unresectable Gastric Cancer.
    Otowa Y; Suzuki S; Kanaji S; Harada H; Tanaka T; Yamamoto M; Matsuda Y; Oshikiri T; Nakamura T; Kakeji Y
    Anticancer Res; 2018 Apr; 38(4):2363-2368. PubMed ID: 29599362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea.
    Jo JC; Baek JH; Koh SJ; Kim H; Min YJ; Lee BU; Kim BG; Jeong ID; Cho HR; Kim GY
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):282-7. PubMed ID: 25856172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of adjuvant chemotherapy cycles on prognosis of resectable stomach cancer: a retrospective analysis.
    Zhang WY; Zhang WJ; Bai Y; Yuan HH; Liu F; Gao J; Gong YF; Jiang B
    Asian Pac J Cancer Prev; 2013; 14(1):381-6. PubMed ID: 23534757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.